Posted by Michael Wonder on 11 Sep 2018
ABPI hits out at ‘punitive’ UK medicines cost controls
11 September 2018 - Steep rise in charges an 'alarming signal' amid Brexit uncertainty
New UK government plans to sharply increase rebates from pharma medicines sales have been roundly criticised by the industry.
Yesterday saw the government unveil its plans for an updated Statutory Scheme, a ‘back up’ plan for companies not in the main PPRS pricing system.
